Evidence map›Paper›PMID 31801496›Full record

ArticleBMC public health2019

Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey.

Ahmad Wali, Dawood Khan, Nauman Safdar, Zeenat Shawani, Razia Fatima, Aashifa Yaqoob, Aurangzeb Qadir, Sultan Ahmed, Hamayun Rashid, Bashir Ahmed and 1 more

Abstract read
In one paragraph

Article in BMC public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Number needed to screen for TB in clinical, structural or occupational risk groups.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
    Pooled it
  4. Pooled it
  5. A systematic review of the number needed to screen for active TB among people living with HIV.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2021
    Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ahmad WaliProvincial Tuberculosis Control Program, Health Department Government of Balochistan, Building Western Bypass Link Brewery Road, Quetta, Balochistan, Pakistan. dr_wali786@yahoo.com.ORCID http://orcid.org/0000-0002-1484-244X
Dawood KhanProvincial AIDS Control Program, Quetta, Balochistan, Pakistan.
Nauman SafdarSocial and Health Inequalities Network Pakistan, Quetta, Pakistan.
Zeenat ShawaniProvincial Tuberculosis Control Program, Health Department Government of Balochistan, Building Western Bypass Link Brewery Road, Quetta, Balochistan, Pakistan.
Razia FatimaNational Tuberculosis Control Program, Ministry of NHSR&C, Islamabad, Pakistan.
Aashifa YaqoobNational Tuberculosis Control Program, Ministry of NHSR&C, Islamabad, Pakistan.
Aurangzeb QadirNational Tuberculosis Control Program, Ministry of NHSR&C, Islamabad, Pakistan.
Sultan AhmedProvincial Tuberculosis Control Program, Health Department Government of Balochistan, Building Western Bypass Link Brewery Road, Quetta, Balochistan, Pakistan.
Hamayun RashidMercy Corps, Quetta, Pakistan.
Bashir AhmedProvincial Tuberculosis Control Program, Health Department Government of Balochistan, Building Western Bypass Link Brewery Road, Quetta, Balochistan, Pakistan.
Shereen KhanFaculty of Bolan Medical University, Quetta, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman Immunodeficiency Virus (HIV), Hepatitis, and Tuberculosis (TB) are three primary communicable infections have the likely potential to cause severe morbidity in prison settings. The prison has the most favorable environment for the transmission of infections. We conducted this survey to determine the prevalence and feasibility of rapid diagnostic tests in an active screening of these infectious diseases in prison.

methodsThis cross-sectional survey conducted in central Jail Gaddani, one of the largest prisons in the Balochistan province of Pakistan. All prisoners, jail staffs, and staff's family members participated. Informed consent obtained from each participant before the screening. Van equipped with digital X-ray linked with Computer-Aided Detection for TB (CAD4TB) software used for testing. Sputum samples tested on Xpert for MTB/RIF assay and blood specimens collected for HIV and hepatitis serology. Diagnosed TB patients enrolled for treatment at Basic Management Unit (BMU), reactive on hepatitis Rapid Diagnostic Tools (RDTs) were referred for further testing and management, while HIV reactive referred to Anti Retro Viral (ARV) center for Anti Retro Viral Treatment (ART).

resultsA total of 567 participants offered screening, 63% (356) prisoners, 23% (129) staff's family members, and 14% (82) jail staffs. Among tested 10.3% (58/562) were hepatitis seropositive (Hepatitis-C 41 [7.29%] Hepatitis-B, 16 [2.84%] Hepatitis B&C both, 01 [0.17%]). In reactive participants, 49 were prisoners, 08 were jail staffs, and 01 was the staff's family member. HIV seropositive was 4% (24/566), and all were prisoners. Almost 99% (565/567) screened by digital X-ray, 172 (30%) were with abnormal CAD4TB suggestion (score > 50), out of them sputum of 26% (148) tested on Xpert, and 2% (03) found Mycobacterium tuberculosis Positive (MTB+). A total of five TB patients were detected; out of two were diagnosed clinically. Co-morbidities observed in 15 patients, (01 TB/HIV co-infected, 12 HIV/HCV, 01 HIV/HBV, and 01 HBV/HCV).

conclusionThe high frequency of infectious diseases in prison is alarming. For limiting the transmission of infections among prison and community, immediate steps are needed to be taken for improvement of prisons condition by application of recommended screening protocols at the time of the first entry of prisoners in prisons.

Indexed as

Acquired Immunodeficiency SyndromeAdultComorbidityCross-Sectional StudiesFemaleHepatitis BHepatitis CHepatitis C AntibodiesHIV InfectionsHumansMaleMass ScreeningMiddle AgedPakistanPrevalencePrisonersHepatitis C AntibodiesActive-case-findingCAD4TBHepatitisHIVPrevalencePrisonScreeningTuberculosis

Identifiers

PMID31801496
PMCPMC6894348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.